Ultrasound patches represent a transformative advancement beyond conventional ultrasonography, evolving into intelligent theranostic systems for personalized healthcare. This evolution is propelled by synergistic innovations in flexible piezoelectric materials and integrated designs. The development of piezoelectric polymers, lead-free ceramics, and bio-composite materials has laid the foundation for long-term, conformal, and biosafe interfacing with the human body. Structurally, miniaturized transducer arrays (e.g., CMOS-integrated arrays achieving ~200 μm focal spots and 100 kPa focal pressure), multimodal integration, and bioinspired interfaces have enabled high-precision deep-tissue sensing and spatiotemporally controlled energy delivery—exemplified by strain-sensing feedback improving the signal-to-noise ratio by 5 dB for precise neuromodulation. These capabilities are converging to create closed-loop platforms, as demonstrated in continuous cardiovascular monitoring (up to 164 mm depth for 12 h), image-guided neuromodulation for neurological disorders, on-demand drug delivery (achieving 100% higher plasma concentration than ultrasound alone), and integrated tumor therapy with real-time feedback. Despite persistent challenges in material biocompatibility, energy efficiency, and clinical standardization, the future of ultrasound patches lies in their deep integration with multimodal sensing, machine learning, and adaptive control algorithms. This path will ultimately realize their potential for intelligent, closed-loop theranostics in chronic disease management, telemedicine, and personalized therapy.
Zhao et al. (Tue,) studied this question.